Document Detail


Angiotensin-converting enzyme inhibitor-induced renal failure: causes, consequences, and diagnostic uses.
MedLine Citation:
PMID:  2103846     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Angiotensin-converting enzyme inhibitor-induced renal failure is now a well-recognized phenomenon that appears to occur almost exclusively in patients with a preexisting reduction in renal perfusion pressure, especially those with renovascular disease. In the latter group of patients, renal failure probably results from some combination of reduced poststenotic renal perfusion pressure and a unique disturbance in the autoregulation of glomerular filtration rate. Although traditionally regarded as functional and reversible, recent animal studies suggest that angiotensin-converting enzyme inhibitor-induced reductions of glomerular filtration rate may lead to progressive renal atrophy, an observation that raises concerns about the long-term safety of these agents in patients with renovascular disease. On the other hand, the deleterious consequences of angiotensin-converting enzyme inhibition in renovascular disease have been exploited as aids in the diagnosis of this disorder. Whether the adjunctive use of angiotensin-converting enzyme inhibitors will prove to be useful in screening large populations of hypertensive patients for renovascular hypertension remains to be determined. However, such adjunctive tests appear to be useful in judging the functional significance of angiographically documented renal artery stenosis.
Authors:
D E Hricik; M J Dunn
Related Documents :
3530566 - Successful use of captopril in the treatment of "scleroderma renal crisis".
19835466 - Renal protective effect of raas blockade across the renal continuum, with a review of t...
2668976 - Decreased renal preglomerular microvascular pgi2 and pge2 biosynthesis in cholesterol-f...
2455836 - Effects of cocaine and nomifensine on canine renal venous norepinephrine and dopamine c...
15162466 - Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy a...
7679836 - Randomized trial of fk 506/prednisone vs fk 506/azathioprine/prednisone after renal tra...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of the American Society of Nephrology : JASN     Volume:  1     ISSN:  1046-6673     ISO Abbreviation:  J. Am. Soc. Nephrol.     Publication Date:  1990 Dec 
Date Detail:
Created Date:  1991-10-17     Completed Date:  1991-10-17     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9013836     Medline TA:  J Am Soc Nephrol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  845-58     Citation Subset:  IM; X    
Affiliation:
Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / adverse effects*,  diagnostic use,  therapeutic use
Humans
Hypertension, Renovascular / diagnosis,  drug therapy,  physiopathology
Kidney Failure, Acute / chemically induced*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The fatty acids available to wild herbivores from indigenous plants is dependent on both plant speci...
Next Document:  Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney.